SummaryJoin Avalere experts for Part 1 of our Market Access Enablement Strategies webinar series to learn about how life sciences companies are pivoting with pre-/post-new product launch strategies, including differential investments to inform market access execution.
From value, evidence, and pricing to access, coverage, and reimbursement to insights and commercialization strategy, the COVID-19 pandemic has created new challenges for innovative life sciences companies to bring products to market. Join our experts to learn about the approaches that can be taken in this virtual era to support stakeholder engagement and patient uptake.
- Pre-/post-launch planning
- Third-party channel and distribution
- Patient access strategy
- Customer models and engagement
Don’t forget to register for Part 2 of our Market Access webinar series.
produces measurable results. Let's work together.